This study is looking at how well a mobile health van can deliver lenacapavir (LEN PrEP), a long-acting injectable medication for preventing HIV, to people experiencing housing instability in Los Angeles County. Many people who are unhoused face challenges getting HIV prevention care in traditional clinics. This study aims to see if providing LEN PrEP through mobile vans, which already offer other health services, can help overcome these barriers. The main goal is to measure how many people start using LEN PrEP after three months. You may be able to join if you are at least 18 years old, speak English or Spanish, have an unknown or negative HIV status, and are considered at risk for HIV by a clinician. The study is currently unclear on its recruitment status, but plans to enroll 100 participants.

Study design

This is an observational study, meaning researchers will watch and record information without assigning specific treatments. It plans to enroll 100 participants.

What's involved

You would need to be reached by a UCLA HHC mobile van, provide informed consent, and be willing and able to follow study procedures. The study will assess your HIV status on the day of enrollment.

Compensation

Not stated in the trial record.

Follow-up

The study will measure the uptake of LEN PrEP at 3 months after you enroll.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.